{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:03:54Z","timestamp":1790024634825,"version":"4.0.1"},"reference-count":25,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Rheumatoid arthritis (RA) disease activity during disease-modifying antirheumatic drug (DMARD) tapering is commonly monitored using in-person clinical assessment and the 28-joint Disease Activity Score with C-reactive protein (DAS28-CRP). Although effective, this approach is resource intensive and may be inconvenient for patients. Remote monitoring with patient-reported outcomes and wearable sensors may enable earlier flare detection and support safer, more personalized tapering pathways. Prior pilot work suggests that accelerometry-derived physical activity, mobility, and sleep metrics correlate with RA disease activity and are acceptable to patients.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This protocol aims to evaluate the feasibility and diagnostic accuracy of remote monitoring for detecting RA flare during DMARD tapering. The study will (1) continuously measure physical activity and quality metrics using wrist-worn accelerometers, (2) collect weekly Rheumatoid Arthritis Flare Questionnaire (RA-FQ) scores, (3) develop and evaluate dynamic risk prediction models using longitudinal accelerometry-derived measurements to estimate the risk of clinically confirmed flare, (4) retrospectively assess prediction accuracy against patient-reported flare, and (5) develop and evaluate a combined dynamic prediction model incorporating longitudinal accelerometry-derived measurements and total RA-FQ scores to assess whether the addition of the RA-FQ improves the prediction of clinically confirmed flare.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This prospective, single-center observational cohort study is embedded within the Rheumatoid Arthritis DMARD Tapering (ROADMAP) clinic at Freeman Hospital, Newcastle upon Tyne, United Kingdom. Adults with clinician-confirmed RA in remission who are undergoing or are about to begin DMARD tapering will be recruited, with a target sample of 100 participants. Participants will be followed for 12 months, with clinical assessments aligned with routine ROADMAP visits at baseline and approximately months 3, 6, 9, and 12 together with ad hoc visits for suspected flare. Continuous wrist-worn accelerometry and weekly RA-FQ responses will be collected throughout follow-up. Clinical assessments will include tender and swollen joint counts, patient and physician visual analog scales, C-reactive protein, the DAS28-CRP, and Health Assessment Questionnaire Disability Index scores. The primary outcome is time to first clinically confirmed flare, defined as DAS28-CRP\u22652.4 and\/or at least 1 swollen joint attributable to inflammatory RA activity. Dynamic risk prediction methods, such as landmarking models, will use longitudinal accelerometry-derived physical activity, mobility, gait, and sleep measures to estimate flare risk over prespecified prediction horizons. Model performance will be assessed using time-dependent discrimination, calibration, predictive values, and lead time before clinically confirmed flare.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The first participant was recruited in October 2025. As of July 2026, 16 participants had been recruited. This protocol reports the study design and planned analyses; outcome analyses will be conducted after recruitment and 12-month follow-up are complete.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study will provide pilot evidence on the feasibility and accuracy of multimodal remote monitoring for RA flare detection during DMARD tapering in routine care. Findings will inform model refinement, external validation, and future larger multicenter studies evaluating clinical utility and service impact.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/99594","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:00:06Z","timestamp":1786734006000},"page":"e99594-e99594","source":"Crossref","is-referenced-by-count":0,"title":["Remote Monitoring for Rheumatoid Arthritis Flare During Drug Tapering: Protocol for a Prospective Observational Cohort Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8589-2420","authenticated-orcid":false,"given":"Javad","family":"Sarvestan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-7283","authenticated-orcid":false,"given":"Marzieh","family":"Shahmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5686-9071","authenticated-orcid":false,"given":"Najla","family":"Elndari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-126X","authenticated-orcid":false,"given":"James MS","family":"Wason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-4751","authenticated-orcid":false,"given":"Silvia","family":"Del Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6735-2911","authenticated-orcid":false,"given":"Kenneth F","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"7","key":"R1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/rheumatology\/41.7.793","article-title":"The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century","volume":"41","author":"Symmons","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"R2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","journal-title":"JAMA"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"R4","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaf124","article-title":"Tapering towards drug-free remission in rheumatoid arthritis: assessment of clinical outcomes and drug savings","volume":"9","author":"Bradley","journal-title":"Rheumatol Adv Pract"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","journal-title":"Arthritis Rheum"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.06.009","article-title":"Predicting drug-free remission in rheumatoid arthritis: a prospective interventional cohort study","volume":"105","author":"Baker","journal-title":"J Autoimmun"},{"issue":"10","key":"R7","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","article-title":"Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria","volume":"43","author":"Fransen","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"R8","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1093\/rheumatology\/keae112","article-title":"Remote monitoring of patients with rheumatoid arthritis in a low disease activity state: a mixed methods evaluation across six hospitals in London, UK","volume":"63","author":"Watson","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003363","article-title":"Recommendation to implementation of remote patient monitoring in rheumatology: lessons learned and barriers to take","volume":"9","author":"Hamann","journal-title":"RMD Open"},{"issue":"2","key":"R10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000202","article-title":"Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis","volume":"2","author":"Hendrikx","journal-title":"RMD Open"},{"issue":"10","key":"R11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3899\/jrheum.161145","article-title":"Content and construct validity, reliability, and responsiveness of the rheumatoid arthritis flare questionnaire: OMERACT 2016 workshop report","volume":"44","author":"Bartlett","journal-title":"J Rheumatol"},{"issue":"17","key":"R12","doi-asserted-by":"publisher","DOI":"10.3390\/s20174797","article-title":"Wearable activity trackers in the management of rheumatic diseases: where are we in 2020?","volume":"20","author":"Davergne","journal-title":"Sensors (Basel)"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2024-eular.2897","article-title":"AB0531 Digital biomarkers of physical activity and sleep are associated with laboratory measures of inflammation in rheumatoid arthritis","volume":"83","author":"Sarvestan","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12010018","article-title":"Exploring the effect of sampling frequency on real-world mobility, sedentary behaviour, physical activity and sleep outcomes measured with wearable devices in rheumatoid arthritis: feasibility, usability and practical considerations","volume":"12","author":"Sarvestan","journal-title":"Bioengineering (Basel)"},{"issue":"11","key":"R15","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3899\/jrheum.141520","article-title":"Flare rate in patients with rheumatoid arthritis in low disease activity or remission when tapering or stopping synthetic or biologic DMARD: a systematic review","volume":"42","author":"Kuijper","journal-title":"J Rheumatol"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","journal-title":"CMAJ"},{"issue":"5","key":"R17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","journal-title":"J Chronic Dis"},{"issue":"6","key":"R18","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/annrheumdis-2013-204920","article-title":"How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?","volume":"74","author":"Fleischmann","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"R19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","journal-title":"Arthritis Rheum"},{"issue":"19","key":"R20","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1080\/02640414.2022.2147134","article-title":"Stepping up with GGIR: validity of step cadence derived from wrist-worn research-grade accelerometers using the Verisense step count algorithm","volume":"40","author":"Rowlands","journal-title":"J Sports Sci"},{"issue":"10","key":"R21","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1249\/MSS.0000000000000978","article-title":"Raw accelerometer data analysis with GGIR R-package: does accelerometer brand matter?","volume":"48","author":"Rowlands","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1123\/jmpb.2022-0018","article-title":"Processing of accelerometry data with GGIR in Motor Activity Research Consortium for Health","volume":"6","author":"Guo","journal-title":"J Meas Phys Behav"},{"issue":"3","key":"R23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1123\/jmpb.2018-0063","article-title":"GGIR: a research community\u2013driven open source R package for generating physical activity and sleep outcomes from multi-day raw accelerometer data","volume":"2","author":"Migueles","journal-title":"J Meas Phys Behav"},{"issue":"5","key":"R24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1183\/09031936.00134312","article-title":"Validity of physical activity monitors during daily life in patients with COPD","volume":"42","author":"Rabinovich","journal-title":"Eur Respir J"},{"issue":"4","key":"R25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-092478","article-title":"Clinical predictors of FLARE and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study","volume":"15","author":"Rayner","journal-title":"BMJ Open"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:22:01Z","timestamp":1790022121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e99594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2196\/99594","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"v15i7e99594"}}